4.8 Article

Glyoxal as an alternative fixative to formaldehyde in immunostaining and super-resolution microscopy

Journal

EMBO JOURNAL
Volume 37, Issue 1, Pages 139-159

Publisher

WILEY
DOI: 10.15252/embj.201695709

Keywords

fixation; glyoxal; immunocytochemistry; PFA; super-resolution Microscopy

Funding

  1. Deutsche Forschungsgemeinschaft through the Collaborative Research Center [889, 1002, 1190]
  2. European Research Council [ERC-CoG-614765]
  3. ERC [ERCAdG 339580, 638314]
  4. Boehringer Ingelheim Fonds
  5. ITN TAMPting network (People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7) under the Research Executive Agency) [607072]
  6. EMBO Long-Term Fellowship [ALTF 232-2016]
  7. Netherlands Organization for Scientific Research [NWO-ALW 016.Veni.171.097]
  8. German Center for Cardiovascular Research, DZHK
  9. Open Philanthropy project
  10. HHMI-Simons Faculty Scholars Program
  11. US-Israel Binational Science Foundation [2014509]
  12. Medical Research Council [MR/K01563X/1] Funding Source: researchfish
  13. European Research Council (ERC) [638314] Funding Source: European Research Council (ERC)
  14. MRC [MR/K01563X/1] Funding Source: UKRI

Ask authors/readers for more resources

Paraformaldehyde (PFA) is the most commonly used fixative for immunostaining of cells, but has been associated with various problems, ranging from loss of antigenicity to changes in morphology during fixation. We show here that the small dialdehyde glyoxal can successfully replace PFA. Despite being less toxic than PFA, and, as most aldehydes, likely usable as a fixative, glyoxal has not yet been systematically tried in modern fluorescence microscopy. Here, we tested and optimized glyoxal fixation and surprisingly found it to be more efficient than PFA-based protocols. Glyoxal acted faster than PFA, cross-linked proteins more effectively, and improved the preservation of cellular morphology. We validated glyoxal fixation in multiple laboratories against different PFA-based protocols and confirmed that it enabled better immunostainings for a majority of the targets. Our data therefore support that glyoxal can be a valuable alternative to PFA for immunostaining.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available